ClearBridge Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$3.89M Hold
2022
Q4
$3.69M Buy
2022
Q3
$3.02M Sell
2022
Q2
$3.04M Sell
2022
Q1
$3.5M Sell
2021
Q4
$3.74M Buy
2020
Q4
Sell
2020
Q3
$9.62M Hold
2020
Q2
$9.01M Buy